What is Biomarker?
The high prevalence of cancer is encouraging research initiatives, driving the growth of the market. Extensive research and technological advancements used for the development of biomarker-based clinical diagnostics are projected to be the key contributors to the market. A rising number of Contract Research Organizations (CROs) is anticipated to further fuel the demand. Biomarkers which are also known as a molecular marker or signature molecule are used to check how the body responds to the treatment of any condition or disease. In simple words, they are used to examine organ functions and other health conditions. They are also used in imaging technology so that they can provide clear imaging of oncology tumors and other problems. They are also used in clinical studies to determine the effect and results of drugs in the early stage.
The market study is broken down by Type (Safety Biomarkers, Efficacy Biomarkers [Predictive Biomarkers, Prognostic Biomarkers, Pharmacodynamic Biomarkers, Surrogate Biomarkers] and Validation Biomarkers), by Application (Diagnostics, Personalized Medicine, Drug Discovery and Development, Disease Risk Assessment and Others) and major geographies with country level break-up. According to AMA, the Global Biomarker market is expected to see growth rate of 13.6%
The global biomarkers market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of the biomarkers market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa. Research Analyst at AMA estimates that Players from United States will contribute to the maximum growth of Global Biomarker market throughout the predicted period.
QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (United States), Merck Millipore (United States), Bio-Rad Laboratories, Inc. (United States), Enzo Biochem, Inc. (United States), Thermo Fisher Scientific Inc. (United States), F. Hoffmann-La Roche Ltd (Switzerland), Abbott Laboratories (United States), EKF Diagnostics (Germany) and Meso Scale Diagnostics, LLC (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Signosis (Germany).
AdvanceMarketAnalytics has segmented the market of Global Biomarker market by Type, Application and Region.
On the basis of geography, the market of Biomarker has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2019. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Product, the sub-segment i.e. Consumables will boost the Biomarker market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Disease Indication, the sub-segment i.e. Cancer will boost the Biomarker market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Leaders and their expansionary development strategies
In March 2020, F. Hoffmann-La Roche Ltd announced the approval by the US Food and Drug Administration (FDA) for its CINtec PLUS Cytology as the first biomarker-based triage test for women whose primary cervical cancer screening results are positive for the human papillomavirus (HPV) using the Cobas 4800 HPV Test
In November 2019, Merck and Personalis, a cancer genomics company, entered into a partnership to identify and develop novel clinical biomarkers for cancer therapies. Under the terms of the partnership, Merck plans to use Personalis’ newest cancer immunogenomics platform ImmunoID NeXT for clinical biomarker identification and development
- Increasing Number of Cros and Low Cost of Clinical Trials in Developing Countries
- High Prevalence of Cancer
- Increasing diagnostic applications of biomarkers
- Increasing R&D Funding for Pharma and Biotech Companies
- Emerging Economies
- New Initiatives for Biomarker Research
- High capital investments and low cost-benefit ratio
- Poorly Suited Regulatory and Reimbursement Systems
- Proving the clinical validity in biomarker-based tests
Key Target AudienceGovernment Regulatory Bodies, Government Research Organization, Private Research Organization and Others
About ApproachDuring this study the evaluation and validation of the market size is done through various sources including primary and secondary analysis. AMA Research & Media follows industrial and regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase